Eversept Partners as of Dec. 31, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 59 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix | 11.4 | $21M | 563k | 36.46 | |
| GlaxoSmithKline | 11.3 | $20M | 530k | 38.51 | |
| R1 Rcm | 10.3 | $19M | 2.3M | 7.95 | |
| Amarin Corporation (AMRN) | 9.5 | $17M | 1.3M | 13.61 | |
| Sanofi-Aventis SA (SNY) | 7.4 | $13M | 306k | 43.41 | |
| Radius Health | 5.0 | $9.1M | 552k | 16.49 | |
| Aerie Pharmaceuticals | 4.7 | $8.4M | 233k | 36.10 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.4 | $6.0M | 37k | 165.71 | |
| Danaher Corporation (DHR) | 2.7 | $4.9M | 48k | 103.28 | |
| Abiomed | 2.5 | $4.5M | 14k | 325.06 | |
| Sarepta Therapeutics (SRPT) | 2.5 | $4.4M | 41k | 109.13 | |
| Argenx Se (ARGX) | 2.0 | $3.7M | 38k | 96.07 | |
| Merck & Co (MRK) | 1.9 | $3.5M | 46k | 77.03 | |
| Ensign (ENSG) | 1.8 | $3.3M | 86k | 38.83 | |
| Arena Pharmaceuticals | 1.8 | $3.2M | 81k | 38.95 | |
| Teligent | 1.7 | $3.1M | 2.2M | 1.37 | |
| Tesaro | 1.5 | $2.7M | 36k | 74.25 | |
| Abbott Laboratories (ABT) | 1.3 | $2.3M | 31k | 72.32 | |
| Fate Therapeutics (FATE) | 1.2 | $2.1M | 165k | 12.83 | |
| Qiagen Nv | 1.1 | $1.9M | 55k | 34.45 | |
| Illumina (ILMN) | 0.8 | $1.5M | 5.1k | 299.92 | |
| Genomic Health | 0.8 | $1.5M | 24k | 64.40 | |
| Mylan Nv | 0.8 | $1.5M | 55k | 27.40 | |
| Deciphera Pharmaceuticals (DCPH) | 0.8 | $1.5M | 70k | 20.99 | |
| Loxo Oncology | 0.8 | $1.4M | 10k | 140.10 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $1.4M | 107k | 13.19 | |
| BioSpecifics Technologies | 0.7 | $1.3M | 22k | 60.59 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $1.3M | 164k | 8.07 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $1.3M | 205k | 6.31 | |
| Array BioPharma | 0.7 | $1.3M | 90k | 14.25 | |
| Foamix Pharmaceuticals | 0.6 | $1.1M | 295k | 3.59 | |
| Affimed Therapeutics B V | 0.6 | $1.0M | 336k | 3.11 | |
| ArQule | 0.5 | $955k | 345k | 2.77 | |
| Caretrust Reit (CTRE) | 0.5 | $956k | 51k | 18.65 | |
| Ascendis Pharma A S (ASND) | 0.5 | $956k | 15k | 62.67 | |
| Tricida | 0.5 | $956k | 41k | 23.59 | |
| Puma Biotechnology (PBYI) | 0.5 | $861k | 42k | 20.35 | |
| Sage Therapeutics (SAGE) | 0.4 | $792k | 8.3k | 95.76 | |
| Amicus Therapeutics (FOLD) | 0.3 | $601k | 63k | 9.58 | |
| Anthem (ELV) | 0.3 | $604k | 2.3k | 262.61 | |
| Natera (NTRA) | 0.3 | $552k | 40k | 13.96 | |
| Centene Corporation (CNC) | 0.3 | $496k | 4.3k | 115.35 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $435k | 51k | 8.62 | |
| Dicerna Pharmaceuticals | 0.2 | $439k | 41k | 10.69 | |
| Albireo Pharma | 0.2 | $442k | 18k | 24.52 | |
| Cymabay Therapeutics | 0.2 | $371k | 47k | 7.88 | |
| Invacare Corporation | 0.2 | $318k | 74k | 4.30 | |
| Seaspine Holdings | 0.2 | $282k | 16k | 18.24 | |
| Tg Therapeutics (TGTX) | 0.1 | $267k | 65k | 4.11 | |
| Opiant Pharmaceuticals | 0.1 | $201k | 14k | 14.46 | |
| Epizyme | 0.1 | $157k | 25k | 6.17 | |
| Aquinox Pharmaceuticals | 0.1 | $159k | 74k | 2.16 | |
| Thermo Fisher Scientific (TMO) | 0.1 | $106k | 475.00 | 223.16 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $108k | 1.6k | 67.92 | |
| Aptar (ATR) | 0.1 | $103k | 1.1k | 94.50 | |
| Conformis | 0.0 | $49k | 137k | 0.36 | |
| Mylan N V call | 0.0 | $36k | 1.6k | 22.70 | |
| Eiger Biopharmaceuticals | 0.0 | $10k | 1.0k | 9.80 | |
| Celgene Corp right 12/31/2011 | 0.0 | $3.0k | 6.0k | 0.50 |
